Mifepristone (Korlym) for Cushing's syndrome.
D003480:Cushing Syndrome / Q000188:drug therapy*; D017277:Drug Approval; D006727:Hormone Antagonists / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D015735:Mifepristone / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D006727:Hormone Antagonists; D015735:Mifepristone